AstraZeneca | Investor Event Presentation Deck | 52 slides · page 28 of 52
The slide uses a matrix structure to segment the market by disease stage and molecular profile, overlaying clinical trial names (e.g., AEGEAN, FLAURA) as product markers.
Conference presentation · kpi_overview · quantify_opportunity · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 disclaimer 1/1 list 1/1 table 1/1 title 2/2
Components 6
primary disclaimer bullet data action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1